These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7196800

  • 1. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M, Baker LH, Opipari M, Al-Sarraf M.
    Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
    Al-Sarraf M, Frank J, Smith JA, O'Bryan RM, Costanzi JJ, Stephens RL, Caraveo J, Crawford ED.
    Cancer Treat Rep; 1985 Feb; 69(2):189-94. PubMed ID: 2578880
    [Abstract] [Full Text] [Related]

  • 3. [Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer].
    Nakagawa S, Nakao M, Toyoda K, Nukui M, Takada H, Ebisui K, Watanabe H, Furusawa T, Maegawa M, Kaiho H.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3071-7. PubMed ID: 3674892
    [Abstract] [Full Text] [Related]

  • 4. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.
    Martino S, Samal B, Al-Sarraf M.
    Cancer Treat Rep; 1980 Jan; 64(1):161-3. PubMed ID: 7379051
    [Abstract] [Full Text] [Related]

  • 6. [M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
    Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Kume T, Masu C, Ishino T, Nakatsu H.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2577-82. PubMed ID: 2673046
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 12. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
    Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter B, Burger RA, Liao S.
    J Clin Oncol; 2004 Oct 01; 22(19):3902-8. PubMed ID: 15459211
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for poor prognosis patients with urothelial tumors and effect of dose intensity.
    Hibi H, Okamura K, Takashi M, Shimoji T, Miyake K.
    Hinyokika Kiyo; 1997 Feb 01; 43(2):89-96. PubMed ID: 9086342
    [Abstract] [Full Text] [Related]

  • 15. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
    Bajorin DF, McCaffrey JA, Dodd PM, Hilton S, Mazumdar M, Kelly WK, Herr H, Scher HI, Icasiano E, Higgins G.
    Cancer; 2000 Apr 01; 88(7):1671-8. PubMed ID: 10738226
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Chemotherapy of metastatic urothelial carcinoma].
    Kihara K, Sakuramoto T, Washizuka M, Kawai T, Ogawa M.
    Gan To Kagaku Ryoho; 1982 Nov 01; 9(11):2046-7. PubMed ID: 6892194
    [Abstract] [Full Text] [Related]

  • 18. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL, Sheen TS, Ko JY, Hsu MM, Wang CC, Ting LL.
    Br J Cancer; 1999 Aug 01; 80(12):1962-7. PubMed ID: 10471046
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic experience of advanced urothelial tract tumors.
    Nakada T, Akiya T, Yoshikawa M, Umeda K, Katayama T.
    Hinyokika Kiyo; 1985 Apr 01; 31(4):601-6. PubMed ID: 4041118
    [Abstract] [Full Text] [Related]

  • 20. CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma.
    van Slooten H, van Oosterom AT.
    Cancer Treat Rep; 1983 Apr 01; 67(4):377-9. PubMed ID: 6687835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.